ExoRehab X is not covered by the insurance. However, up to 24-month financing options will be available for qualified individuals to make our technology affordable. The goal is to keep monthly costs below the average cost of a single clinical session out of pocket cost.
Delivery times varies from state to state, but the estimated delivery is between 4-6 weeks.
ExoRehab X is a Class-I FDA-listed device. In a controlled clinical study, it has been shown that chronic stage stroke survivors achieved on average 2.96 times higher improvement in the capability of carrying out activities of daily living compared to the control group, which received conventional therapy (measured with Fugl-Meyer Assessment – FMA).